Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $5 | $6 | $10 |
| - Cash | $4 | $4 | $4 | $6 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $1 | $3 | $4 | $5 |
| Revenue | $2 | $2 | $2 | $3 |
| % Growth | 2.2% | -14.7% | -28.2% | – |
| Gross Profit | $1 | $1 | $1 | $2 |
| % Margin | 65.3% | 69.6% | 68.2% | 80% |
| EBITDA | $0 | $0 | -$2 | $1 |
| % Margin | 5.5% | 18% | -70.7% | 30.7% |
| Net Income | -$0 | -$0 | -$2 | $0 |
| % Margin | -11.4% | -2.9% | -87.8% | 13.7% |
| EPS Diluted | -0.023 | -0.006 | -0.21 | 0.044 |
| % Growth | -303.4% | 97.2% | -578.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |